Sana Biotechnology Inc at Citi BioPharma Conference Transcript

Sep 06, 2023 / 02:30PM GMT
Samantha Lynn Semenkow - Citigroup Inc., Research Division - VP

All right, welcome. Thank you everyone. It's a pleasure here to host Steve Harr, CEO of Sana Biotechnology. Steve, thank you for being with us today.

Steven D. Harr - Sana Biotechnology, Inc. - President, CEO & Director

(inaudible).

Samantha Lynn Semenkow - Citigroup Inc., Research Division - VP

I want to if both mics working.

Steven D. Harr - Sana Biotechnology, Inc. - President, CEO & Director

Can you hear me now? There we go.

Questions and Answers:

Samantha Lynn Semenkow - Citigroup Inc., Research Division - VP

All right. Great. Well, then maybe you can just start us off for those that are a little bit less familiar with Sana, and just giving maybe a 2-minute high-level overview of the company, what you do, where you're working towards.

Steven D. Harr - Sana Biotechnology, Inc. - President, CEO & Director
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot